Tolerability and effectiveness of low-dose oral minoxidil for alopecia in patients with breast cancer: A retrospective cohort study.

Autor: Zaminski D; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Sikora M; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York; New York Medical College, Valhalla, New York. Electronic address: msikora@student.nymc.edu., Nohria A; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Desai D; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Buontempo M; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York; Hackensack Meridian School of Medicine, Nutley, New Jersey., Caplan AS; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Lacouture M; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Garshick M; Leon H. Charney Division of Cardiology, New York University Grossman School of Medicine, New York, New York., Olsen EA; Departments of Dermatology and Medicine, Duke University School of Medicine, Durham, North Carolina., Shapiro J; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Mazori DR; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Lo Sicco KI; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Dec 03. Date of Electronic Publication: 2024 Dec 03.
DOI: 10.1016/j.jaad.2024.11.048
Abstrakt: Competing Interests: Conflicts of interest Dr Lo Sicco is a consultant for Pfizer and Aquis. Dr Shapiro is a consultant for Aclaris Therapeutics, Incyte, and RepliCel Life Sciences. Drs Lo Sicco and Shapiro have been investigators for Regen Lab and are investigators for Pfizer. Dr Olsen reports serving as a consultant for Myovant, Pfizer, Lilly, and Kintor, and having another relationship with UpToDate. Dr Garshick is a consultant for BMS, Horizon Therapeutics, Agepha, and Kiniksa. Dr Lacouture is a consultant for AZ, Novartis, Marengo, Hoth, Novocure, Kintara, Lutris, and OnQuality. Drs Zaminski, Sikora, Nohria, Desai, Buontempo, Caplan, and Mazori have no conflicts of interest to declare.
Databáze: MEDLINE